These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35819704)

  • 41. Unilateral hypercalciuria: a stealth culprit in recurrent ipsilateral urolithiasis in children.
    Tasian GE; Ziemba J; Casale P
    J Urol; 2012 Dec; 188(6):2330-5. PubMed ID: 23088966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Etiology, urine metabolic risk factors, and urine oxalate patterns in patients with significant hyperoxaluria and recurrent nephrolithiasis.
    Moore JP; Mauler DJ; Narang GL; Stern KL; Humphreys MR; Keddis MT
    Int Urol Nephrol; 2022 Nov; 54(11):2819-2825. PubMed ID: 35917078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.
    Rodriguez Cuellar CI; Wang PZT; Freundlich M; Filler G
    Pediatr Nephrol; 2020 Mar; 35(3):383-397. PubMed ID: 30607567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of whole-exome sequencing to identify novel monogenic gene mutations and genotype-phenotype correlations in Chinese Han children with urolithiasis.
    Wang Z; He T; Liu L; Tong F; Li C; Zhao Y; Li Y
    Front Genet; 2023; 14():1128884. PubMed ID: 37144129
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Etiologic and epidemiologic pattern of urolithiasis in north iran;review of 10-year findings.
    Mohammadjafari H; Barzin M; Salehifar E; Khademi Kord M; Aalaee A; Mohammadjafari R
    Iran J Pediatr; 2014 Feb; 24(1):69-74. PubMed ID: 25793048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biochemical diagnosis in 3040 kidney stone formers in Argentina.
    Spivacow FR; del Valle EE; Negri AL; Fradinger E; Abib A; Rey P
    Urolithiasis; 2015 Aug; 43(4):323-30. PubMed ID: 25958053
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recurrent symptomatic urolithiasis in a patient with cystic fibrosis.
    Yel S; Dursun I; Köse M; Kiraz A; Poyrazoglu MH; Dündar M
    Pediatr Nephrol; 2024 Jun; ():. PubMed ID: 38916781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hereditary hypophosphatemic rickets with hypercalciuria and nephrolithiasis-identification of a novel SLC34A3/NaPi-IIc mutation.
    Phulwani P; Bergwitz C; Jaureguiberry G; Rasoulpour M; Estrada E
    Am J Med Genet A; 2011 Mar; 155A(3):626-33. PubMed ID: 21344632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review of childhood genetic nephrolithiasis and nephrocalcinosis.
    Gefen AM; Zaritsky JJ
    Front Genet; 2024; 15():1381174. PubMed ID: 38606357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urine risk factors in children with calcium kidney stones and their siblings.
    Bergsland KJ; Coe FL; White MD; Erhard MJ; DeFoor WR; Mahan JD; Schwaderer AL; Asplin JR
    Kidney Int; 2012 Jun; 81(11):1140-8. PubMed ID: 22358148
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nephrolithiasis.
    Scheinman SJ
    Semin Nephrol; 1999 Jul; 19(4):381-8. PubMed ID: 10435676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High Prevalence of Hypocitraturia in Stone Formers from the Maya Region of Yucatan, Mexico.
    Basulto-Martínez M; Peña-Espinoza B; Valdez-Ortiz R; Escalante-Sosa R; Flores-Tapia JP; Menjivar M
    Arch Med Res; 2022 Jan; 53(1):69-78. PubMed ID: 34243991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic causes of hypercalciuric nephrolithiasis.
    Stechman MJ; Loh NY; Thakker RV
    Pediatr Nephrol; 2009 Dec; 24(12):2321-32. PubMed ID: 18446382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study of Urine Composition of Patients With Recurrent Nephrolithiasis in Lorestan, Iran.
    Hadian B; Zafar-Mohtashami A; Ghorbani F
    Iran J Kidney Dis; 2018 Jan; 12(1):22-26. PubMed ID: 29421773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TRPV5 in renal tubular calcium handling and its potential relevance for nephrolithiasis.
    van der Wijst J; van Goor MK; Schreuder MF; Hoenderop JG
    Kidney Int; 2019 Dec; 96(6):1283-1291. PubMed ID: 31471161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic evaluation of children with urolithiasis.
    Gouru VR; Pogula VR; Vaddi SP; Manne V; Byram R; Kadiyala LS
    Urol Ann; 2018; 10(1):94-99. PubMed ID: 29416283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The growing prevalence of kidney stones and opportunities for prevention.
    Richman K; O'Bell J; Pareek G
    R I Med J (2013); 2014 Dec; 97(12):31-4. PubMed ID: 25463625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Etiology and treatment of urolithiasis.
    Pak CY
    Am J Kidney Dis; 1991 Dec; 18(6):624-37. PubMed ID: 1962646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic disturbances in Chinese children with urolithiasis: a single center report.
    Yang D; Tiselius HG; Lan C; Chen D; Chen K; Ou L; Liu Y; Xu S; Zeng G; Lei M; Wu W
    Urolithiasis; 2017 Jun; 45(3):285-290. PubMed ID: 27510800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis and Management of Nephrolithiasis in Children.
    Kovacevic L
    Pediatr Clin North Am; 2022 Dec; 69(6):1149-1164. PubMed ID: 36880927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.